XML 105 R31.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Business Combinations (Tables)
12 Months Ended
Oct. 31, 2019
Business Combinations [Abstract]  
Schedule of recognized identified assets acquired and liabilities assumed
The following table summarizes the allocation of the purchase price to the fair values assigned to the CMW assets acquired and liabilities assumed. These fair values are based on internal company and independent external third-party valuations (in thousands):
 
 
April 1, 2019
Cash and cash equivalents
 
$
16,341

Receivables
 
65,674

Inventories
 
241,429

Prepaid expenses and other current assets
 
9,218

Property, plant and equipment
 
142,779

Goodwill
 
135,521

Other intangible assets
 
264,190

Other long-term assets
 
7,971

Accounts payable
 
(36,655
)
Accrued liabilities
 
(52,258
)
Deferred income tax liabilities
 
(86,231
)
Other long-term liabilities
 
(6,665
)
Total fair value of net assets acquired
 
701,314

Less: cash and cash equivalents acquired
 
(16,341
)
Total purchase price
 
$
684,973


Finite-lived and indefinite-lived intangible assets acquired as part of business combination
The fair values of the other intangible assets acquired on the closing date, related accumulated amortization from the closing date through October 31, 2019, and weighted-average useful lives were as follows (in thousands, except weighted-average useful life):
 
 
Weighted-Average Useful Life
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net
Customer-related
 
18.3
 
$
130,800

 
$
(4,981
)
 
$
125,819

Developed technology
 
7.8
 
20,900

 
(2,019
)
 
18,881

Trade names
 
20.0
 
5,200

 
(152
)
 
5,048

Backlog
 
0.5
 
3,590

 
(3,590
)
 

Total amortizable
 
16.6
 
160,490

 
(10,742
)
 
149,748

Non-amortizable - trade names
 
 
 
103,700

 

 
103,700

Total other intangible assets, net
 
 
 
$
264,190

 
$
(10,742
)
 
$
253,448


Business acquisition, pro forma information
The following table presents unaudited pro forma financial information for fiscal 2019 and 2018 (in thousands, except per share data):
 
 
October 31, 2019
 
October 31, 2018
Net sales
 
$
3,437,335

 
$
3,332,636

Net earnings1
 
363,452

 
276,722

Basic net earnings per share of common stock
 
3.40

 
2.60

Diluted net earnings per share of common stock1
 
$
3.36

 
$
2.55

1 
On January 1, 2019, CMW amended its retiree medical plans so that no employee hired, or rehired, after that date would be eligible for such retiree medical plans. CMW further amended its retiree medical plans on February 14, 2019 so that no employee who terminates employment after February 14, 2019 is eligible to participate in the retiree medical plans and to terminate its retiree medical plans effective December 31, 2019. The amendments and resulting termination of CMW's retiree medical plans resulted in a gain of approximately $45.8 million. This gain is reflected within net earnings in the unaudited pro forma financial information for the fiscal year ended October 31, 2019. The impact on diluted net earnings per share of common stock for the fiscal year ended October 31, 2019 was $0.42 per diluted share of common stock.